Hui Yannian, Wang Lin, Huang Wei, Han Quanhong, Wang Ying
Department of Ophthalmology, The Eye Institute of PLA, Xijing Hospital, The Fourth Military Medical University, Xi'an, 710032, China.
Zhonghua Yan Ke Za Zhi. 2002 Oct;38(10):598-602.
To evaluate the efficacy of cataract extraction and simultaneous intraocular lens (IOL) implantation during vitreous surgery for treatment of a series of patients with proliferative diabetic retinopathy (PDR) and cataract.
A consecutive series of PDR treated with vitrectomy and simultaneous IOL implantation during February 1997 and October 2001 was retrospectively analyzed.
The series included 37 cases (12 males and 25 females) 44 eyes (OD 13; OS 17 and OU 7) with diabetic history for 1 - 30 years and eye symptoms for 40 days to 10 years. Surgical techniques included lensectomy or phacofragmentation via the pars plana. The anterior capsule was preserved and the epithelium was suctioned and scraped off. After vitreous surgery and endolaser, IOL was inserted via the corneoscleral incision on the anterior capsule, of which the center area 5 mm in diameter was cut. The patients was followed-up for 3 months to 4.5 years, mean (16 +/- 13) months. Visual acuity was light perception, hand motion, finger count, 0.02, and 0.1 - 0.2 in 5, 14, 11, 6, and 8 (18.2%) eyes, respectively before operation. Postoperatively, visual improvement was achieved in 41 eyes with 0.1 - 1.0 in 35 eyes (79.5%). Visual acuity remained unchanged in 2 eyes and decreased in one eye. Eyes with lower vision were associated with marked macular edema, hard exudates and severe ischemia. Six eyes had mild corneal edema 2 approximately 5 days after operation. Corneal ulcer or neovascular glaucoma occurred in 2 eyes 5 months after surgery.
Cataract extraction and simultaneous IOL implantation during vitreous surgery for PDR may improve the visual outcome in the majority of selected eyes without significant complications.
评估玻璃体手术中白内障摘除联合人工晶状体(IOL)植入术治疗一系列增殖性糖尿病视网膜病变(PDR)合并白内障患者的疗效。
回顾性分析1997年2月至2001年10月期间连续接受玻璃体切除术联合IOL植入术治疗的PDR患者。
该系列包括37例患者(男性12例,女性25例)共44只眼(右眼13只;左眼17只,双眼7例),糖尿病病史1至30年,眼部症状持续40天至10年。手术技术包括经睫状体平坦部进行晶状体切除术或晶状体超声粉碎术。保留前囊膜,吸除并刮除上皮。玻璃体手术和眼内激光治疗后,通过在直径5mm的前囊膜中央区域切开的角巩膜切口植入IOL。患者随访3个月至4.5年,平均(16±13)个月。术前视力为光感、手动、指数、0.02以及0.1 - 0.2的眼分别有5只、14只、11只、6只和8只(18.2%)。术后,41只眼视力得到改善,其中35只眼(79.5%)视力达到0.1 - 1.0。2只眼视力无变化,1只眼视力下降。视力较低的眼与明显的黄斑水肿、硬性渗出和严重缺血有关。6只眼术后约2至5天出现轻度角膜水肿。2只眼术后5个月发生角膜溃疡或新生血管性青光眼。
玻璃体手术中为PDR患者进行白内障摘除联合IOL植入术可使大多数选定的眼视力改善且无明显并发症。